Norway· NO-ID_CC3B0565-AF8F-4FF2-9D34-ED0B4EA886BE
Lonquex
A lipegfilgrastim product containing lipegfilgrastim, registered in Norway by Teva B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Lipegfilgrastim is registered in 12 of 19 countries.
Countries holding a registration under ATC L03AA14 (lipegfilgrastim), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Lipegfilgrastim · ATC L03AA14
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Lipegfilgrastim
- Manufacturer
- Teva B.V.
- Country
- Norway (NO)
- ATC code
- L03AA14
- ATC class
- Lipegfilgrastim
- Defined daily dose
- 0.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- gtin7046261033794
- no_merkevare_idID_CC3B0565-AF8F-4FF2-9D34-ED0B4EA886BE
- no_varenummer1033790.6NOK 8937.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lipegfilgrastim in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLONQUEXTeva B.V., Haarlem
- BelgiumLonquex 6 mgTeva
- SpainLonquex 6mg solucion inyectableTeva B.V.
- IcelandLonquexTeva B.V.*
- SwedenLonquex 6 mg Injektionsvätska, lösning i förfylld sprutaTeva B.V.
- FinlandLonquexTeva B.V.
- IrelandLonquex 6 mg solution for injection in pre-filled syringeTeva B.V.
- FranceLONQUEX 6 mg, solution injectable en seringue préremplieTEVA (PAYS-BAS)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Lonquex
- Iceland · Lonquex
- Liechtenstein · Lonquex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/18258318-5e59-4af1-9d64-e0932185d4bd GET /v1/drugs/18258318-5e59-4af1-9d64-e0932185d4bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Lipegfilgrastim",
"merkevare_id": "ID_CC3B0565-AF8F-4FF2-9D34-ED0B4EA886BE",
"name_form_strength": "Lonquex inj, oppl 6 mg/sprøyte",
"prescription_group": "C"
}See everything about lipegfilgrastim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.